LPS-induced NFκB enhanceosome requires TonEBP/NFAT5 without DNA binding

NFκB is a central mediator of inflammation. Present inhibitors of NFκB are mostly based on inhibition of essential machinery such as proteasome and protein kinases, or activation of nuclear receptors; as such, they are of limited therapeutic use due to severe toxicity. Here we report an LPS-induced...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hwan Hee, Sanada, Satoru, An, Seung Min, Ye, Byeong Jin, Lee, Jun Ho, Seo, Young-Kyo, Lee, Changwook, Lee-Kwon, Whaseon, Küper, Christoph, Neuhofer, Wolfgang, Choi, Soo Youn, Kwon, Hyug Moo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847014/
https://www.ncbi.nlm.nih.gov/pubmed/27118681
http://dx.doi.org/10.1038/srep24921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847014/
https://www.ncbi.nlm.nih.gov/pubmed/27118681
http://dx.doi.org/10.1038/srep24921

Ejemplares similares